Intuitive Surgical, Inc. (ISRG)
NASDAQ: ISRG · Real-Time Price · USD
541.82
+3.00 (0.56%)
At close: Nov 20, 2024, 4:00 PM
542.78
+0.96 (0.18%)
Pre-market: Nov 21, 2024, 7:11 AM EST

Company Description

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.

The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights.

The company sells its products through direct sales organizations, such as capital and clinical sales teams.

It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Intuitive Surgical, Inc.
Intuitive Surgical logo
Country United States
Founded 1995
IPO Date Jun 13, 2000
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 13,676
CEO Gary Guthart

Contact Details

Address:
1020 Kifer Road
Sunnyvale, California 94086-5304
United States
Phone 408 523 2100
Website intuitive.com

Stock Details

Ticker Symbol ISRG
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001035267
CUSIP Number 46120E602
ISIN Number US46120E6023
Employer ID 77-0416458
SIC Code 3842

Key Executives

Name Position
Dr. Gary S. Guthart Ph.D. Chief Executive Officer and Director
David J. Rosa President and Director
Jamie E. Samath Senior Vice President and Chief Financial Officer
Henry L. Charlton Senior Vice President and Chief Commercial and Marketing Officer
Robert DeSantis Executive Vice President and Chief Strategy and Corporate Operations Officer
Fredrik Widman Vice President, Principal Accounting Officer and Corporate Controller
Brian King Vice President, Treasurer and Head of Investor Relations
Gary H. Loeb J.D. Senior Vice President, General Counsel and Chief Compliance Officer
Dr. Christopher R. Carlson Ph.D. Executive Vice President of Research, Corporate Development and Intuitive Ventures
Patricia Wadors Chief Human Resources Officer

Latest SEC Filings

Date Type Title
Nov 12, 2024 144 Filing
Nov 12, 2024 144 Filing
Nov 12, 2024 144 Filing
Nov 8, 2024 144 Filing
Oct 30, 2024 144 Filing
Oct 30, 2024 144 Filing
Oct 29, 2024 144 Filing
Oct 28, 2024 144 Filing
Oct 28, 2024 144 Filing
Oct 25, 2024 144 Filing